Disease Burden and Hospital-Associated Risk
On World Thrombosis Day, the International Society on Thrombosis and Haemostasis (ISTH) and Science Writers in New York (SWINY) invite you to attend an intimate and timely discussion on venous thromboembolism (VTE; blood clots in the legs and lungs) with distinguished speaker, Dr. Gary E. Raskob.
Tuesday, October 13, 6:30 to 8:30 p.m.
101 Park Ave (at 41st street) at Grand Central, 1st Floor Lounge
Gary E. Raskob, PhD
Dean, College of Public Health
Regents Professor of Epidemiology and Medicine
University of Oklahoma Health Sciences Center
*Special video introduction from Dr. Tom Frieden, Director of the CDC
Shannon Toher (email@example.com)
*Seats are limited
This event is offered free of charge to health and science journalists. Complimentary appetizers and drinks will be served.
VTE is the leading preventable cause of premature death and disability in hospitals worldwide – ahead of infection and pneumonia. In the U.S., an estimated 540,000 hospitalized patients develop VTE yearly and 100,000-300,000 deaths are attributed to the disease.
Patients who survive VTE can face debilitating effects and an increased risk for recurrent events. In the U.S. and abroad, awareness of the condition is low and many survivors and caregivers feel ill-prepared to understand and manage it.
Under the Affordable Care Act’s Hospital Acquired Condition (HAC) Reduction program, hundreds of hospitals face financial penalties for Patient Safety Indicator (PSI-90) scores for poor VTE rates. With VTE-related healthcare costs already as high as $10 billion a year, prevention and awareness of this condition is critical.
Dr. Gary Raskob will discuss the global burden of VTE and evidence-based prevention measures that can reduce unnecessary death and disability – especially in the hospital setting.
To learn more about World Thrombosis Day visit www.worldthrombosisday.org. More than 275 partners in 65 countries have 450 events planned on or around October 13.